Skip to main content

Table 3 Outcome measure scores and effect estimates adjusted from baseline

From: Effects of a footwear intervention on foot pain and disability in people with gout: a randomised controlled trial

 

Footwear intervention group mean (SD)

Control group mean (SD)

Adjusted effect estimate

P

Foot pain VAS

 Baseline

14.8 (18.7)

17.5 (22.4)

  

 2 months

10.7 (13.0)

16.8 (21.8)

− 5.0 (− 12.9 to 2.8)

0.21

 4 months

13.8 (23.0)

16.1 (22.3)

− 1.8 (− 10.1 to 6.4)

0.66

 6 months

13.1 (20.8)

20.5 (26.1)

− 6.7 (− 16.4 to 2.9)

0.17

Overall pain VASa

 Baseline

18.7 (19.6)

17.7 (23.9)

  

 2 months

9.7 (13.6)

23.3 (27.5)

− 13.2 (− 22.2 to − 4.3)

< 0.01

 4 months

16.2 (19.4)

17.9 (22.8)

− 2.3 (− 0.5 to 0.6)

0.65

 6 months

16.3 (19.2)

20.7 (26.8)

− 4.0 (− 13.6 to 5.7)

0.42

Patient Global Assessment VASa

 Baseline

22.7 (24.5)

21.5 (25.8)

  

 2 months

17.7 (24.2)

16.4 (21.6)

1.2 (− 7.4 to 9.9)

0.78

 4 months

14.6 (16.6)

16.6 (20.2)

− 2.8 (− 11.9 to 6.3)

0.55

 6 months

15.3 (19.4)

18.8 (21.9)

− 3.4 (− 12.6 to 5.7)

0.46

Health Assessment Questionnaire II

 Baseline

0.5 (0.6)

0.4 (0.5)

  

 2 months

0.5 (0.6)

0.4 (0.4)

− 0.1 (− 0.3 to 0.1)

0.36

 4 months

0.6 (0.6)

0.3 (0.5)

0.0 (−0.2 to 0.2)

0.84

 6 months

0.5 (0.5)

0.4 (0.6)

− 0.1 (− 0.3 to 0.1)

0.28

LFIS total score

 Baseline

15.5 (11.5)

15.4 (12.5)

  

 2 months

13.8 (13.0)

16.4 (14.1)

− 4.7 (− 9.1 to − 0.3)

0.04

 4 months

14.9 (14.2)

14.2 (12.3)

− 1.3 (− 6.1 to 3.5)

0.59

 6 months

14.4 (13.6)

16.9 (14.2)

− 3.0 (0.2 to 1.8)

0.21

LLTQ activities of daily l

 Baseline

32.7 (8.2)

33.8 (6.8)

  

 2 months

34.8 (7.2)

32.9 (8.0)

2.2 (− 0.2 to 4.6)

0.07

 4 months

32.9 (8.1)

35.4 (6.7)

− 0.4 (− 3.1 to 2.3)

0.77

 6 months

34.0 (6.9)

33.8 (7.7)

1.1 (− 1.2 to 3.4)

0.35

LLTQ recreational activitiesb

 Baseline

22.7 (11.8)

21.1 (11.6)

  

 2 months

23.5 (14.2)

22.8 (11.5)

0.8 (− 2.8 to 4.4)

0.66

 4 months

20.8 (12.8)

25.1 (9.9)

− 3.4 (− 7.5 to 0.8)

0.11

 6 months

21.7 (12.6)

22.2 (12.0)

− 0.9 (− 4.8 to 3.0)

0.66

Footwear comfort VASc

 Baseline

24.0 (21.9)

27.6 (28.0)

  

 2 months

10.3 (13.1)

26.2 (26.5)

− 10.4 (− 19.9 to − 0.9)

0.03

 4 months

9.1 (9.8)

24.0 (21.0)

− 11.3 (− 21.4 to − 1.3)

0.03

 6 months

17.5 (23.5)

27.9 (28.4)

− 8.0 (− 19.2 to 3.3)

0.16

Footwear fit VASd

 Baseline

20.6 (20.1)

24.0 (27.2)

  

 2 months

9.8 (16.0)

22.2 (21.3)

− 9.5 (− 17.2 to − 1.8)

0.02

 4 months

10.3 (13.6)

22.2 (20.4)

− 11.1 (− 19.9 to − 2.4)

0.01

 6 months

11.9 (20.0)

27.9 (28.4)

− 11.1 (− 21.1 to − 1.0)

0.03

Footwear ease VASe

 Baseline

20.9 (23.0)

19.3 (23.8)

  

 2 months

12.7 (19.1)

26.8 (28.2)

− 9.8 (− 19.4 to − 0.3)

0.04

 4 months

10.2 (16.6)

23.8 (25.2)

− 12.3 (− 23.0 to − 1.6)

0.02

 6 months

11.3 (19.7)

27.9 (28.4)

− 13.2 (− 23.8 to − 2.7)

0.01

Footwear weight VASd

 Baseline

21.9 (21.9)

22.7 (24.6)

  

 2 months

12.7 (17.8)

27.0 (26.6)

− 9.7 (− 19.5 to 0.0)

0.05

 4 months

13.6 (20.3)

24.6 (20.4)

− 10.8 (− 20.6 to − 0.9)

0.03

 6 months

11.4 (19.7)

27.9 (28.4)

− 10.3 (− 19.8 to − 0.8)

0.03

  1. VAS visual analogue scale, LFIS Leeds Foot Impact Scale, LLTQ Lower Limb Tasks Questionnaire
  2. aBMI adjusted
  3. bAge adjusted
  4. cBMI and prednisone adjusted
  5. dSex and BMI adjusted
  6. eEthnicity and BMI adjusted
  7. Data in italics indicates statistical significance